StrykerSYK
About: Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Employees: 52,000
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
35% more first-time investments, than exits
New positions opened: 151 | Existing positions closed: 112
2% more funds holding
Funds holding: 1,947 [Q2] → 1,986 (+39) [Q3]
9% more repeat investments, than reductions
Existing positions increased: 779 | Existing positions reduced: 712
4% more capital invested
Capital invested by funds: $102B [Q2] → $106B (+$4.01B) [Q3]
10% less call options, than puts
Call options by funds: $579M | Put options by funds: $641M
1.51% less ownership
Funds ownership: 78.74% [Q2] → 77.23% (-1.51%) [Q3]
3% less funds holding in top 10
Funds holding in top 10: 77 [Q2] → 75 (-2) [Q3]
Research analyst outlook
14 Wall Street Analysts provided 1 year price targets over the past 3 months
14 analyst ratings
Truist Securities Richard Newitter 80% 1-year accuracy 40 / 50 met price target | 12%upside $409 | Hold Maintained | 18 Dec 2024 |
Needham Mike Matson 50% 1-year accuracy 58 / 117 met price target | 21%upside $442 | Buy Maintained | 12 Dec 2024 |
Citigroup Joanne Wuensch 55% 1-year accuracy 26 / 47 met price target | 23%upside $450 | Buy Maintained | 11 Dec 2024 |
RBC Capital Shagun Singh 51% 1-year accuracy 40 / 78 met price target | 17%upside $425 | Outperform Reiterated | 11 Dec 2024 |
Wells Fargo Larry Biegelsen 51% 1-year accuracy 24 / 47 met price target | 17%upside $427 | Overweight Maintained | 11 Dec 2024 |
Financial journalist opinion
Based on 9 articles about SYK published over the past 30 days
